gvtcx

Pandemic Resilience, Supply & R&D Agreement for mRNA vaccines

Department of Health and Social Care Published 16 Jan 2023 Contracts Finder

key details

Value£1
Statuscomplete
Category (CPV) 73300000 +1 more
Deadline19 Dec 2022
Contract start20 Dec 2022
Contract end19 Dec 2032
SME suitableNo
OCIDocds-b5fd17-83a6476a-a078-43aa-850d-798ed271d529

Awards (2)

This procurement was awarded to 1 suppliers. Values shown are per-award; the notice total is £1.

SupplierValueDateStatus
MODERNA BIOTECH UK LIMITED £1 20 Dec 2022 active
MODERNA BIOTECH UK LIMITED · · active

description

The contract is to establish UK-based mRNA vaccine development and manufacturing capability to support the UK's preparedness and resilience for future pandemics and health emergencies. The objective of security of supply in such circumstances is to be met by the construction of a mRNA manufacturing facility sited within the UK which will work alongside UK-based fill/finish providers to supply vaccines. In addition, the contract also includes certain commitments for the supplier to invest in R&D in the field of mRNA vaccines and therapeutics within the UK.

notice history

2 notices published against this procurement.

PublishedTypeRegimeNotice
16 Jan 2023 Award (award) · 0beddce4-3ec5-4c4e-87ec-9f2ca8817a01-605772
18 Jan 2023 Contract award notice (F03) Earlier regulations 001501-2023

more from Department of Health and Social Care

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.